- Victor Grifols Roura, who devoted 50 years to constructing Grifols in management positions together with CEO for 30 years, is retiring as Non-Govt Chairman and appointed Honorary Chairman in recognition of his many contributions
- Steve F. Mayer, former co-head of International Personal Fairness and chairman of the funding committee of a non-public funding firm Cerberus capital administration, L.P., with greater than 10 years as Griffols unbiased member of the board of administrators, is appointed government chairman
- The adjustments additional mirror the board’s give attention to strategic targets, operational excellence and deleveraging stability sheet
Barcelona, Spain, October 3, 2022 /PRNewswire/ — Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS) at present introduced adjustments to its management group, appointing Mr. Steven F. Mayer as Govt Chairman whereas Mr. Victor Grifols Roura retired as Chairman and was appointed Honorary Chairman. Each adjustments take impact instantly.
These unanimously accepted appointments reveal the Board’s dedication to strengthening Grifols’ management; speed up the execution of the corporate’s strategic plan; proceed to give attention to operational excellence; and enhance worth for all shareholders, with a give attention to decreasing debt ranges and bettering the corporate’s money profile.
“I’ve spent most of my grownup life actively main Grifols, and with the corporate essentially sound and within the arms of robust management, it was time for me to retire. It has been an honor to chair Grifols Board of Administrators and managing the enterprise for therefore lengthy. I’ve identified Steven since he joined our Board of Administrators after we acquired Talecris in 2011 and I do know that his expertise, insights, expertise, in-depth information and vital capital markets experience shall be invaluable property to our administration group as he helps steer Grifols ahead.” stated Mr. Victor Grifols Roura, now Honorary Chairman of the Grifols Board of Administrators.
“It’s a privilege to observe Victor as Chairman of this vital world healthcare firm, and I stay up for taking over this position at such an vital time for Grifols. Though Victor’s sneakers are not possible to satisfy, I’m delighted to work alongside the Board of Administrators, Co-CEOs and your entire administration group, utilizing my experience to assist them obtain the corporate’s strategic targets and give attention to the operational excellence; sustainable income, profitability and money circulation progress; and strengthening the corporate’s stability sheet. It’s equally vital to me to make sure that the core values of integrity, respect , inclusion and sustainability of the corporate that Victor has established and that Victor has at all times adhered to, in addition to his dedication to the well being and well-being of sufferers world wide, will proceed to information the corporate and his complete group. go ahead “, stated Mr. Steven F. Mayernow Govt Chairman of the Board of Grifols.
Mr. Mayer has intensive healthcare information and expertise and is properly versed within the plasma-derived protein therapeutics trade, having led the group that acquired and spun off Talecris Biotherapeutics from Bayer Healthcare and subsequently grew income and the corporate’s worker base and considerably improved its profitability and money circulation till its merger with Grifols in 2011, when he joined the Grifols Board of Administrators. Along with the board of Grifols, he has served on the boards or equal our bodies of over 30 different private and non-private corporations in quite a lot of industries. Previous to his retirement in 2018 from Cerberus, which at present manages roughly $60 billion of Capital, as Senior Managing Director, Co-Head of International Personal Fairness and Chairman of its Funding Committee, Mr. Mayer targeted on alternatives to enhance the competitiveness and worth of portfolio corporations by way of operational planning and execution in addition to strategic initiatives and monetary self-discipline.
In parallel, Mr. Victor Grifols Roura will proceed to be a member of the Grifols Board of Administrators and a priceless useful resource as “Director Proprietor” and has additionally been named Honorary Chairman because of his invaluable contributions, management unwavering and extraordinary dedication to the corporate.
“It’s not possible to say sufficient about what Victor has meant for Grifols and its complete ecosystem, and specifically for the sufferers whose lives the corporate has improved, everywhere in the world” stated Carina SzpilkaLead Unbiased Director of the Grifols Board of Administrators. “Victor was the person liable for taking Grifols from a small, predominantly Spanish firm 20 years in the past and, by way of his imaginative and prescient, ardour, experience and management, reworking it into the worldwide healthcare chief in billions of {dollars} he has grow to be at present. The whole Board of Administrators is grateful to Victor and dedicated to honoring his legacy by capitalizing on the various strengths of the corporate and the momentum of the trade. whereas overseeing the administration group’s continued execution of its strategic plan.We all know that Steven’s appointment as Govt Chairman will facilitate the achievement of those objectives.He has the total help of the entire board members of administration and our dedication to robust governance practices.”
Co-CEO of Grifols, Victor Grifols Deu and Raimon Grifols Rouraadditionally commented on the nominations. “Victor has at all times impressed us and served as a job mannequin as we now have led the enterprise over the previous 5 years, which included the challenges posed by the coronavirus pandemic from which the enterprise is quickly recovering. We now have additionally lengthy appeared as much as Steven each for what he and his group have completed at Talecris and for his insights and contributions to our Board of Administrators, and we’re delighted to introduce him to our prolonged group of world-class leaders and staff. , and dealing with him to create worth for all a continued laser give attention to our strategic plan, operational execution and deleveraging our stability sheet.”
About Steven F. Mayer
Steven F. Mayer has been a director of Grifols, SA since January 2011. He’s at the moment Chairman and CEO of Iron Horse Acquisition Corp. and Dedication Capital, LLC, non-public funding corporations he based. From 2002 to 2018, he held varied government positions at Cerberus Capital Administration, LP and Cerberus California, LLC, affiliated non-public funding corporations, culminating as Senior Managing Director, Co-Head of International Personal Fairness and Chairman of Cerberus Funding Committee. He started his non-public fairness profession as a principal at Apollo Advisors, LP in 1992.
He holds a Bachelor of Arts, cum laude, from princeton college and a Juris Physician diploma, magna cum laude, from Harvard Regulation College and has taught programs at these two establishments in addition to at LUISS, a college in Rome.
Mr. Mayer has served on the board of administrators or equal of numerous companies in all kinds of industries in america and Europe. He’s at the moment a member of the supervisory board of Syntellix, AG and a director of PrettyParty, LLC and 9Squared, LLC.
About Grifols
Grifols is a world healthcare firm based in Barcelona in 1909 dedicated to bettering the well being and well-being of individuals world wide. Its three major enterprise models – Biopharma, Diagnostics and Bio Provides – develop, produce and market revolutionary options and providers which are offered in additional than 110 nations.
Pioneers within the plasma trade, Grifols operates a rising community of donation facilities world wide. It transforms collected plasma into important medication to deal with uncommon, persistent and typically deadly ailments. As a acknowledged chief in transfusion medication, Grifols additionally presents a complete portfolio of options designed to enhance security, from donation to transfusion. Moreover, the corporate gives instruments, data and providers that allow hospitals, pharmacies and healthcare professionals to effectively ship specialised medical care.
Grifols, which has greater than 27,000 staff in additional than 30 nations, is dedicated to a sustainable enterprise mannequin that units the usual for steady innovation, high quality, security and moral management.
In 2021, the financial affect of Grifols in its major nations of operation was €7.7 billion. The corporate additionally generated 141,500 jobs, together with oblique and induced.
The corporate’s Class A shares are listed on the Spanish Inventory Trade, the place they’re a part of the Ibex-35 (MCE: GRF). Grifols non-voting Class B shares are listed on the Mercado Continuo (MCE: GRF.P) and on the US NASDAQ by way of ADRs (NASDAQ: GRFS). For extra data, please go to www.grifols.com
LEGAL DISCLAIMER
Details and figures contained on this report that don’t consult with historic knowledge are “future projections and assumptions”. Phrases and phrases comparable to “consider”, “hope”, “anticipate”, “predict”, “anticipate”, “intend”, “ought to”, “will search to realize”, “it’s estimated”, “future” and comparable expressions, insofar as they relate to the Grifols group, are used to determine future projections and assumptions. These expressions mirror administration’s assumptions, assumptions, expectations and forecasts on the time of writing, and are topic to a variety of elements that imply precise outcomes could also be materially totally different. The long run outcomes of the Grifols group might be affected by occasions associated to its personal actions, comparable to a scarcity of provides of uncooked supplies for the manufacture of its merchandise, the looks of competing merchandise in the marketplace, or adjustments within the regulatory framework of the markets by which it operates, amongst others. On the date of scripting this report, the Grifols group has adopted the required measures to mitigate the potential affect of those occasions. Grifols, SA undertakes no obligation to report publicly, revise or replace future projections or assumptions to adapt them to occasions or circumstances after the date of this report, besides as expressly required by the relevant laws. This doc doesn’t represent a suggestion or an invite to buy or subscribe for shares in accordance with the provisions of the next Spanish laws: Royal Legislative Decree 4/2015, of October 23, approving the recast textual content of the Securities Market Regulation movables; Royal Decree-Regulation 5/2005, of March 11 and/or Royal Decree 1310/2005, of November 4, and any regulation growing this laws. Moreover, this doc doesn’t represent a suggestion to purchase, promote or alternate, nor a request for a suggestion to purchase, promote or alternate securities, nor a request to vote or approve in some other jurisdiction. The data contained on this doc has not been verified or examined by the exterior auditors of the Grifols group.
SOURCE Grifols
